Yousif Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
Other funds holding APLS
Yousif Capital Management's APLS Position: Q2 2026 in Review
Yousif Capital Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 27,997 shares — an estimated $1.13M sold.
Yousif Capital Management first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $1.13M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.
- Yousif Capital Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Yousif Capital Management sold 27,997 Apellis Pharmaceuticals shares in Q2 2026, an estimated $1.13M.
- Yousif Capital Management first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
- Yousif Capital Management's Apellis Pharmaceuticals position peaked at $1.13M in Q1 2026.
- 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.
Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.